Amplification of MDM2 and Loss of p16 Expression: Do They Have a Role in Malignant Transformation of Ovarian Brenner Tumor?
CONCLUSIONS: We are the first to report immunohistochemical expression of MDM2 in an MBT. Amplification of MDM2 and loss of p16 expression may have a role in malignant transformation of BT.
PMID: 32322877 [PubMed - as supplied by publisher]
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Wang L, Allison D, Shukla PS Tags: Am J Clin Pathol Source Type: research
More News: Borderline Tumor | Brenner Tumor | Cancer & Oncology | Genetics | Ovarian Cancer | Ovaries | Pathology